医药生物行业周报(12月第2周):CXO有望迎来修复

世纪证券
Dec 19, 2025

(以下内容从世纪证券《医药生物行业周报(12月第2周):CXO有望迎来修复》研报附件原文摘录)行业观点:周度回顾。上周(12月8日-12月12日)医药生物板块收跌1.04%,跑输Wind全A(0.26%)和沪深300(-0.08%)。从细分板块来看,医疗研发外包(3.69%)是唯一收涨的子版块,线下药店(-4.33%)、医药流通(-4.23%)和血液制品(-4.05%)领跌。从个股来看,昭衍新药(...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10